SEC Form 4 · accession 0001209191-16-128708
Tvardi Therapeutics, Inc. · TVRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey L. Ives
Director
Period of report
Jun 15, 2016
Accepted (ET)
Jun 17, 2016 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001346830
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.32 | Jun 15, 2016 | A | 15,000 | A | — | Jun 15, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1This option was granted to the reporting person pursuant to the issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on June 15, 2017, subject to the reporting person's continued service as a director through such date.